News and Press Releases
AiCuris Received €15m Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients
PREVYMIS now approved in the US and Europe for prophylaxis of Cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R-]) EMA approval...
Category: Pharmaceutical
Posted: January 9, 2024
Friedrich-Ebert-Str. 475 / Building 302 42117 Wuppertal Germany
Premier Research and BioCentriq Enter a Strategic Partnership to Accelerate Pre-IND Timelines and Clinical Translation of Innovative Cell Therapies
8 January 2024 – Morrisville, NC and Newark, NJ, US — Premier Research, a preeminent global clinical research, product development, and consulting company, and BioCentriq, a renowned Contract Development and Manufacturing Organisation...
Category: BioManufacturing, Drug Discovery
Posted: January 9, 2024
Enzene Biosciences launches its first manufacturing base in the US, with additional plans to establish continuous manufacturing operations at its New Jersey site
The company has leased 54,000 square feet of space to host multiple manufacturing lines of its continuous manufacturing technology platform, EnzeneX™. The New Jersey plant can cater to future expansion...
Category: BioManufacturing, Drug Discovery
Posted: January 9, 2024
Plo Number Number 165/1/26,Priyadarshani Society, 26, Internal Rd, next to Gujjar Bharath gas) T, MIDC, Bhosari, Pune, Maharashtra 411026
WuXi AppTec triples peptide manufacturing capacity and launches the new Taixing API manufacturing site
Expansion Boosts Solid-Phase Peptide Synthesis Total Reactor Volume to 32,000 Liters in Response to Surging Demand 8 January 2024 – Shanghai, China – WuXi AppTec – a global company that...
Category: BioManufacturing, Drug Delivery, Manufacturing and Packing
Posted: January 8, 2024
288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, China
Servier and Aitia announce a new collaboration focused on Parkinson’s disease
Aitia's Gemini Digital Twins will help identify subpopulations of patients who could respond favorably to Servier's LRRK2 in development treatment 8 January 2024 – Suresnes, France – Servier, an independent...
Category: Drug Delivery, Drug Discovery
Posted: January 8, 2024
Cherwell joins the AnalytiChem Group of Companies
Leveraging collaboration opportunities to continue to deliver ultra-high-quality products and services while achieving growth ambitions 8 January 2024 – Bicester, UK – Cherwell, cleanroom microbiology solutions expert, is excited to...
Category: BioManufacturing, Manufacturing and Packing
Posted: January 8, 2024
Launton Business Centre Murdock Rd, Bicester OX26 4XB
Calypso Enters into Agreement to Be Acquired by Novartis
Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by developing CALY-002, an anti-IL-15 monoclonal antibody, for an array of autoimmune indications The acquisition of Calypso gives Novartis...
Category: Biotechnology
Posted: January 8, 2024
CordenPharma & pHLIP announce strategic alliance to develop pHLIP LNP targeted delivery platform for RNA & gene therapies
4 January 2024 – Basel, Switzerland / Providence, RI, USA – CordenPharma International (Basel, Switzerland) and pHLIP, Inc. (Kingston, RI) are pleased to announce their strategic alliance to collaborate in...
Category: Drug Delivery, Drug Discovery
Posted: January 5, 2024
Headlands Research Announces Partnership with Sahara Behavioral Health
The collaboration improves access to clinical research and investigational treatments while supporting participant recruitment efforts in Arizona 4 January 2024 -- California, US -- Headlands Research, a leading multinational network...
Category: Clinical Trials
Posted: January 5, 2024
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide
5 January 2024 -- Helsinki, Finland -- Nanoform Finland, the medicine performance enhancing company, today announced it had completed the First Subject First Visit (FSFV) in a trial to evaluate...
Category: Clinical Trials
Posted: January 5, 2024
Aptar Digital Health and Gerresheimer Collaborate to develop integrated solution for subcutaneous cancer therapy
Collaboration aims to deliver an innovative solution to improve overall patient treatment adherence and clinical outcomes 4 January 2024 – Crystal Lake, Illinois US – Aptar Digital Health, a global...
Category: Drug Delivery, Logistics, Manufacturing and Packing, Pharmaceutical
Posted: January 5, 2024
Blue Spark Technologies Adds MaryAnne Rizk to Board of Advisors
Cutting-Edge Remote Patient Monitoring Technology Enhances Leadership with the Appointment of Board of Advisors 4 January 2024 -- Ohio, US -- Blue Spark Technologies, a proven innovative digital health technology...
Category: Biotechnology
Posted: January 4, 2024
New partnership aims to advance vaccine against MERS coronavirus
CEPI to invest up to $47m to develop and stockpile a ready reserve of emergency MERS vaccine candidate, VTP-500 VTP-500 project with Barinthus Bio and University of Oxford, UK, uses...
Category: Clinical Trials
Posted: January 2, 2024
Thermo Fisher Scientific’s PPD Clinical Research Business Selected by BARDA to Support Phase 2 Platform Clinical Trial to Treat Acute Respiratory Distress Syndrome (ARDS)
21 December 2023 -- North Carolina, US -- The PPD clinical research business of Thermo Fisher Scientific Inc, the world leader in serving science, has been selected by the Biomedical...
Category: Clinical Trials
Posted: December 21, 2023
Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT (amivantamab), for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer
The submission is supported by data from the Phase 3 MARIPOSA study, which featured in a Late-Breaking Presidential Symposium session at the 2023 ESMO CongressLazertinib is a highly selective, central...
Category: Clinical Trials
Posted: December 21, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
